KDIGO Opens 2026 Draft Guideline for Public Review: Learn more

Supporting Research

BioPorto offers a unique range of human and animal NGAL ELISA kits for preclinical animal research and Phase 1 human clinical trials.

Join us in changing the kidney care paradigm

Stay up to date with the latest resources for kidney care, and news about BioPorto.

Empowering Early Intervention

Rapidly detect acute kidney injury with The NGAL Test™ (CE-Marked). Unlike traditional methods, an NGAL result identifies kidney damage early, guiding interventions with the potential to prevent irreversible damage. Take confident action now.

Join us in changing the kidney care paradigm

Stay up to date with the latest resources for kidney care, and news about BioPorto.